Categories
Procedure
Features & Benefits
Discharge Delays
Variability in anticoagulant therapy and radial band techniques undermine hemostasis efforts. This leads to compression times over 2 hours, more than half rebleed, and 16% of discharges are delayed.1–4
Stop the Compression Cascade
StatSeal accelerates hemostasis and minimizes hemotomas, enabling faster ambulation and same-day discharge, improving cath lab throughput.1,2
Dramatically Reduce Rebleeds and Recovery Time with StatSeal
Two global randomized controlled trials with 2500+ patients
What a Hemostatic Sealant Does
StatSeal dehydrates and binds blood proteins, using a hydrophilic polymer and potassium ferrate, creating a durable seal without relying on the clotting cascade.5
StatSeal removes the variability in hemostasis, so you can move confidently to your next case.
Built for Every Bleed
Insertion-Site Care
StatSeal helps hospitals protect patients and ease clinician burden. Its patented hypoallergenic formula minimizes dressing disruptions.5–7
- PICC/CVC insertions
- Dialysis catheters
- Peripheral arterial catheters
- Umbilical catheters
- ECMO cannulas
- Temporary hemodynamic support devices
- Drainage catheters
- Tracheostomies
- PEG tubes
Closure
StatSeal accelerates hemostasis and standardizes hospital procedures, shortening recovery, enabling same-day discharge, and reducing complications across a range of high-volume procedures.1–4,6
- Transradial and transfemoral access
- Fistuloplasty
- Venous ablation
- Vascular closure
Order Information
| CATALOG NUMBER | DESCRIPTION | DISC SIZE (IN.) | DISC SIZE (CM) |
| DAR630 | Advanced RAD Disc | 0.94 x 0.47″ | 2.4 x 1.2 cm |
References
1. Proscia et al. 2025. “A Randomised Control Trial to Compare Conventional and Haemostatic Dressings in Radial Arterial Access: Assessment of Radial Artery Complications Whilst Achieving Rapid Haemostasis (ARCH Trial).” Int J Cardiol 420: 132740. doi: 10.1016/j.ijcard.2024.132740.
2. Safirstein et al. 2022. “Radial Hemostasis Is Facilitated with a Potassium Ferrate Hemostatic Patch: The STAT2 Trial.” JACC Cardiovasc Interv 15, no. 8: 810–19. doi: 10.1016/j.jcin.2021.12.030.
3. Bagur et al. 2022. “Postprocedural Radial Artery Compression Time in Chronic AnticoaguLated Patients Using StatSeal: The PRACTICAL-SEAL Study.” Int J Cardiol 346:14–17. doi: 10.1016/j.ijcard.2021.11.011.
4. Ayyaz et al. 2019. “Accelerated Patent Hemostasis Using a Procoagulant Disk; A Protocol Designed to Minimize the Risk of Radial Artery Occlusion Following Cardiac Catheterization.” Cardiovasc Revasc Med 20, no. 2: 137–42. doi: 10.1016/j.carrev.2018.03.026.
5. Hastings and Barton. 2024. “Rapid Haemostasis to Achieve Dressing Longevity: Evaluation Trial Results Using StatSeal Catheter Exit Site Protection.” Br J Nurs 33, no. 14: S8–S14. doi: 10.12968/bjon.2024.0164.
6. Wang et al. 2008. “Comparative Evaluation of Noninvasive Compression Adjuncts for Hemostasis in Percutaneous Arterial, Venous, and Arteriovenous Dialysis Access Procedures.” J Vasc Interv Radiol 19, no. 1: 72–9. doi: 10.1016/j.jvir.2007.08.028.
7. Blough, Hinson, and Hen. 2010. “The Science of a Seal for PICC Line Management: Bio Seal CVC Powder.” J VAS Access 15, no. 2: 66–73.
Before using, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.
408807001_001 ID 062626
Related products